Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

NYSE:BDX) BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...

Gateway Investment Advisers LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by ...

Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang ...

Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...

Shares of Becton Dickinson & Co. BDX advanced 1.60% to $236.30 Thursday, on what proved to be an all-around poor trading ...

Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published ...

Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership ...

"The partnership with BDx Data Centers reflects our focus on optimizing internet traffic, improving routing efficiency, and ...